Pharmabiz

Affordable healthcare innovation will define Viksit Bharat 2047, says Dr R A Mashelkar at FICCI Legends Series

Affordable healthcare innovation will define Viksit Bharat 2047, says Dr R A Mashelkar at FICCI Legends Series: Our Bureau, ...
Pharmabiz

DCOIWA seeks IPCA membership and announces new Hyderabad Training Centre at Daman congress

DCOIWA seeks IPCA membership and announces new Hyderabad Training Centre at Daman congress: Peethaambaran Kunnathoor, Chennai Tuesday, July 14, 2026, 08:00 Hrs [IST] The 4th natio ...
Pharmabiz

NPPA notifies exemption of Biological E's Pneubevax 14 from DPCO pricing

NPPA notifies exemption of Biological E's Pneubevax 14 from DPCO pricing: Gireesh Babu, New Delhi Tuesday, July 14, 2026, ...
Pharmabiz

Celea Therapeutics begins patient dosing in global phase 3 SURPASS-IPF trial of deupirfenidone to treat idiopathic pulmonary fibrosis

Celea Therapeutics begins patient dosing in global phase 3 SURPASS-IPF trial of deupirfenidone to treat idiopathic pulmonary fibrosis: Boston Tuesday, July 14, 2026, 16:00 Hrs [IS ...
Pharmabiz

Lupin recognized among India’s Best Employers in the Nation-Builders category by Great Place To Work India 2026

Lupin recognized among India’s Best Employers in the Nation-Builders category by Great Place To Work India 2026: Our Bureau, Mumbai Tuesday, July 14, 2026, 16:15 Hrs [IST] Globa ...
Pharmabiz

Leiutis Pharma gets CDSCO nod for global-first synthetic CBD therapy for mild to moderate anxiety disorders

Leiutis Pharma gets CDSCO nod for global-first synthetic CBD therapy for mild to moderate anxiety disorders: Our Bureau, Bengaluru Tuesday, July 14, 2026, 16:25 Hrs [IST] Leiutis ...
Pharmabiz

TolerogenixX receives EMA Orphan Drug Designation for MIC-Lx, strengthening its regulatory pathway in kidney transplantation

TolerogenixX, a German clinical-stage biopharmaceutical company developing personalized cell therapies inducing antigen-specific immune tolerance, announced that the European Commission has granted ...
Pharmabiz

Alembic Pharma gets warning letter from USFDA for Vadodara facility

Alembic Pharma gets warning letter from USFDA for Vadodara facility: Our Bureau, Mumbai Tuesday, July 14, 2026, 14:50 Hrs [IST] Alembic Pharmaceuticals Limited stated that the Uni ...
Pharmabiz

Natco Pharma completes acquisition of additional 13.25% stake in Adcock Ingram Holdings

Natco Pharma Limited announced the successful completion of its acquisition of an additional 13.25% equity stake in Adcock Ingram Holdings Proprietary Limited, a leading South African pharmaceutical ...
Pharmabiz

GSK announces positive interim results from registrational phase II AZUR-1 trial of Jemperli in dMMR/MSI-H locally advanced rectal cancer

GSK announces positive interim results from registrational phase II AZUR-1 trial of Jemperli in dMMR/MSI-H locally advanced rectal cancer: London, UK Tuesday, July 14, 2026, 12:00 ...
Pharmabiz

Alamar Biosciences partners with leading research universities to launch national initiative advancing blood-based biomarkers for neurodegenerative diseases

Alamar Biosciences partners with leading research universities to launch national initiative advancing blood-based biomarkers for neurodegenerative diseases: Fremont, California T ...
Pharmabiz

Aethlon Medical continues to observe directional changes in second cohort of Australian oncology clinical trial evaluating Hemopurifier

Aethlon Medical continues to observe directional changes in second cohort of Australian oncology clinical trial evaluating Hemopurifier: San Diego Tuesday, July 14, 2026, 18:00 Hr ...